Press Releases

Bridge Laboratories Reaches Agreement to Build 2nd Facility in Beijing

Gaithersburg, MD – (July 29, 2008)

Bridge Laboratories announced today that it has reached an agreement to build its second preclinical facility in China. This purpose built, 150,000 square foot facility will be adjacent to Bridge’s existing laboratory in the Zhongguancun Life Science Park located in Beijing, China.

Construction of the new laboratory will begin in the fourth quarter of 2008. This state-of-the-art facility, expected to be completed in late fourth quarter 2009 and designed to meet the United States Food and Drug Administration and worldwide regulatory standards, will provide GLP toxicology, immunology, vaccine, and bioanalytical services. This new facility will quadruple Bridge's available laboratory space in Beijing.

"Bridge is committed to providing quality preclinical services to our customers, and this new facility will enable us to expand our ability to deliver US-level regulatory compliant outsourced discovery and development services in a cost effective manner", said Tom Oakley, President and CEO, Bridge Laboratories. "China is becoming a very attractive solution to many multinational pharmaceutical and biotech companies – We have an established presence and are prepared to meet the growing requirements for preclinical services. We are looking forward to using this new facility to expand our relationships with our current customers and to build relationships with new customers who are looking for high-quality, lower cost alternatives for their preclinical development needs," Oakley continued.

About Pharmaron

Founded in 2003, Pharmaron is a leading pharmaceutical and biotechnology drug R&D CRO, with operations in China and the United States. Clients include pharmaceutical, biotechnology, academic and government organizations. As a research-driven and customer-focused company, Pharmaron provides a broad, integrated portfolio of laboratory and manufacturing services from drug discovery to IND submission. These services are designed to help its global partners improve the success of research and shorten the time of development cost effectively in discovering and developing drugs. For more information about Pharmaron, please visit http://www.pharmaron.com.